Immunosuppression and malignancy.
出版信息
Br Med J. 1972 Sep 23;3(5829):713-4.
Abstract
摘要
相似文献
1
Immunosuppression and malignancy.免疫抑制与恶性肿瘤。
Br Med J. 1972 Sep 23;3(5829):713-4.
2
Malignancy and immunosuppression.恶性肿瘤与免疫抑制。
Proc R Soc Med. 1972 Mar;65(3):242. doi: 10.1177/003591577206500305.
3
Another look at immunologic surveillance.再看免疫监视。
N Engl J Med. 1975 Jul 24;293(4):181-4. doi: 10.1056/NEJM197507242930406.
4
Cancer and survival after cadaveric donor renal transplantation.尸体供肾移植后的癌症与生存情况
Transplant Proc. 1979 Mar;11(1):1052-4.
5
[Lymphomata in patients with kidney transplantation].
Harefuah. 1972 May 15;82(10):474-5.
6
A hematologist's appraisal of the problem cerebral lymphomas in transplanted patients. A speculative review.血液学家对移植患者中脑淋巴瘤问题的评估。一篇推测性综述。
Haematologica. 1974 Dec;59(4):489-98.
7
Tumour development following immunosuppression.免疫抑制后的肿瘤发展。
Proc R Soc Med. 1970 Oct;63(10):1077-80. doi: 10.1177/003591577006301055.
8
Tumor incidence in human allograft recipients.人类同种异体移植受者的肿瘤发生率。
Transplant Proc. 1979 Mar;11(1):1047-51.
9
[Malignant tumors under immunosuppression, a new problem in transplant-recipients].[免疫抑制状态下的恶性肿瘤，移植受者面临的新问题]
Helv Chir Acta. 1973 Dec;40(5):773-6.
10
De novo malignancy following liver transplantation: a single-center study.
Transplant Proc. 1993 Feb;25(1 Pt 2):1397-9.
引用本文的文献
1
Upper Gastrointestinal Tract Lymphoma With Natalizumab: Evidence of Impaired Immune Surveillance?那他珠单抗治疗上消化道淋巴瘤：免疫监视受损的证据？
Neurol Clin Pract. 2021 Aug;11(4):e546-e548. doi: 10.1212/CPJ.0000000000000985.
本文引用的文献
1
SOMATIC MUTATION AND CHRONIC DISEASE.体细胞突变与慢性病
Br Med J. 1965 Feb 6;1(5431):338-42. doi: 10.1136/bmj.1.5431.338.
2
Nephrotic syndrome due to primary renal disease in adults: I. Survey of incidence in South-east England.成人原发性肾脏疾病所致肾病综合征：I. 英格兰东南部发病率调查。
Br Med J. 1969 May 31;2(5656):533-5. doi: 10.1136/bmj.2.5656.533.
3
Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis.硫唑嘌呤治疗溃疡性结肠炎、肉芽肿性结肠炎和局限性肠炎。
Am J Dig Dis. 1971 Apr;16(4):327-32. doi: 10.1007/BF02235208.
4
Hazard of immunosuppressive therapy.免疫抑制治疗的风险
Br Med J. 1972 Apr 29;2(5808):291. doi: 10.1136/bmj.2.5808.291.
5
De novo malignant tumors in organ transplant recipients.器官移植受者中的新发恶性肿瘤。
Transplant Proc. 1971 Mar;3(1):773-8.
6
Immunosurveillance and cancer: epidemiological evidence.免疫监视与癌症：流行病学证据
Br Med J. 1970 Nov 14;4(5732):420-2. doi: 10.1136/bmj.4.5732.420.
7
Transplanted carcinoma in an immunosuppressed patient.免疫抑制患者的移植癌
Transplantation. 1970 Jan;9(1):71-4. doi: 10.1097/00007890-197001000-00021.
8
Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.一名接受免疫抑制治疗的系统性红斑狼疮患者发生恶性脑淋巴瘤。
Arthritis Rheum. 1972 Mar-Apr;15(2):183-6. doi: 10.1002/art.1780150207.
9
Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.硫唑嘌呤（依木兰）给药与NZB小鼠恶性淋巴瘤的发生
Clin Exp Immunol. 1968 May;3(4):305-12.
10
Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia.免疫抑制药物治疗自身免疫性溶血性贫血
Proc R Soc Med. 1968 Dec 12;61(12):1312-5. doi: 10.1177/003591576806101237.
Zotero 插件